Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medical Device Regulations In Latin America And The Way Forward

Executive Summary

Akhila Krishnan reviews the different regulatory requirements for medical devices in five Latin American countries and discusses how harmonization initiatives will make things easier for manufacturers in this guest column.

Advertisement

Related Content

Can A Transformed ANVISA Sustain Torrent's Brazilian Mojo?
Medtech Reform Breakthrough As EU Reaches Agreement on Future Regulations
US FDA's Expedited Access Pathway: 17 Medical Devices And Counting
Canadian Medtech Keeps An Eye On Transition To MDSAP; Regulator Won't Allow Grace Period
Brazil Takes Over Chair Of International Device Forum IMDRF
US FDA Emphasizes Timesavers In New eCopy Guidance For Medical Devices
IMDRF To Test Improved Program For Exchanging Info On Medical Device Incidents, Finalizes Strategic Plan For 2020
Two EU notified bodies join international pilot to test common submission format for devices

Topics

Advertisement
UsernamePublicRestriction

Register

MT103586

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel